VR Adviser, LLC Q1 2025 Filing

Filed May 15, 2025

Portfolio Value

$1.2T

Holdings

37

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (37 positions)

#StockSharesValue% PortfolioType
1
APGEAPOGEE THERAPEUTICS INC
8,493,321$317.3B27.00%
2
MTSRMETSERA INC
3,750,662$102.1B8.69%
3
OCULOCULAR THERAPEUTIX INC
12,762,462$93.5B7.96%
4
ELVNENLIVEN THERAPEUTICS INC
4,026,331$79.2B6.74%
5
KALVKALVISTA PHARMACEUTICALS INC
6,703,985$77.4B6.58%
6
VRDNVIRIDIAN THERAPEUTICS INC
3,882,709$52.3B4.45%
7
PHVSPHARVARIS N V
3,112,720$48.9B4.16%
8
SYRESPYRE THERAPEUTICS INC
2,685,448$43.3B3.69%
9
ORKAORUKA THERAPEUTICS INC
4,148,428$42.6B3.62%
10
PRAXPRAXIS PRECISION MEDICINES I
989,985$37.5B3.19%
11
COGTCOGENT BIOSCIENCES INC
5,684,411$34.0B2.90%
12
DNTHDIANTHUS THERAPEUTICS INC
1,744,373$31.6B2.69%
13
DYNDYNE THERAPEUTICS INC
2,173,913$22.7B1.93%
14
CDTXCIDARA THERAPEUTICS INC
1,051,518$22.6B1.93%
15
ENGNENGENE HOLDINGS INC
5,046,414$22.6B1.92%
16
ERASERASCA INC
16,216,216$22.2B1.89%
17
ORICORIC PHARMACEUTICALS INC
3,182,527$17.8B1.51%
18
UPBUPSTREAM BIO INC
2,295,319$14.0B1.20%
19
CATBUSDASTRIA THERAPEUTICS INC
2,457,348$13.1B1.12%
20
CGEMCULLINAN THERAPEUTICS INC
1,379,965$10.4B0.89%
21
SLDBSOLID BIOSCIENCES INC
2,481,400$9.2B0.78%
22
YB4PSAVARA INC
3,257,639$9.0B0.77%
23
ABVXABIVAX SA
1,345,780$8.4B0.72%
24
PERCEPTIVE CAP SOLUTIONS COR
750,000$7.7B0.66%
25
SRZNSURROZEN INC
632,931$7.4B0.63%
26
ZURAZURA BIO LTD
5,023,166$6.5B0.55%
27
ARTVARTIVA BIOTHERAPEUTICS INC
1,609,569$4.8B0.41%
28
TRVITREVI THERAPEUTICS INC
615,506$3.9B0.33%
29
APLTAPPLIED THERAPEUTICS INC
5,567,709$2.7B0.23%
30
FDMT4D MOLECULAR THERAPEUTICS IN
677,600$2.2B0.19%
31
CASI PHARMACEUTICALS INC
987,259$2.1B0.18%
32
TENXTENAX THERAPEUTICS INC
208,333$1.4B0.12%
33
MERSANA THERAPEUTICS INC
3,574,325$1.2B0.10%
34
IPSCCENTURY THERAPEUTICS INC
2,498,069$1.2B0.10%
35
TNYATENAYA THERAPEUTICS INC
1,555,556$886.8M0.08%
36
GLYCEURGLYCOMIMETICS INC
3,000,000$630.0M0.05%
37
TILINSTIL BIO INC
33,177$576.0M0.05%